Today, we would like to highlight one of the key factors that continues to make Eastern Europe an important region for international clinical research: patient recruitment.

Ukraine has long been recognized for its access to diverse patient populations, experienced investigators, and clinical sites familiar with international trial standards. Even in today’s challenging environment, the country continues to demonstrate resilience and operational capacity in clinical research.

According to the European Business Association, from 2022 to 2025, the Ministry of Health of Ukraine approved 199 new clinical trial protocols from 86 sponsors. This reflects not only continued interest from sponsors but also the ability of Ukrainian clinical sites to remain engaged in research under complex conditions.

For international sponsors, Ukraine’s recruitment advantage combines recruitment speed, investigator commitment, patient motivation, therapeutic diversity, and the ability to build strategies that reflect the real clinical landscape.

If you are planning patient recruitment in Ukraine or assessing the country for your next clinical trial, Pharmaxi LLC can support you with feasibility assessment, site identification, recruitment strategy, and clinical trial operations across Ukraine and Eastern Europe to help turn recruitment potential into successful study delivery.